14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.10 $1.87 Friday, 3rd May 2024 AKTX stock ended at $1.36. This is 7.48% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 18.72% from a day low at $1.33 to a day high of $1.58.
90 days $1.10 $2.64
52 weeks $1.10 $5.50

Historical Akari Therapeutics Plc prices

Date Open High Low Close Volume
Feb 23, 2022 $25.80 $25.80 $25.40 $25.40 2 185
Feb 22, 2022 $26.00 $27.60 $25.60 $25.60 4 045
Feb 18, 2022 $27.60 $27.60 $26.00 $26.80 845
Feb 17, 2022 $27.80 $28.00 $27.00 $27.00 5 145
Feb 16, 2022 $30.20 $30.40 $27.80 $27.80 14 690
Feb 15, 2022 $29.40 $30.60 $29.00 $30.58 6 850
Feb 14, 2022 $29.00 $29.40 $28.40 $29.40 6 875
Feb 11, 2022 $27.00 $29.40 $27.00 $29.20 6 795
Feb 10, 2022 $26.42 $27.02 $26.42 $26.60 2 185
Feb 09, 2022 $26.80 $27.20 $26.40 $26.80 3 045
Feb 08, 2022 $26.70 $26.70 $26.40 $26.60 520
Feb 07, 2022 $26.80 $27.40 $26.14 $26.80 1 390
Feb 04, 2022 $27.60 $27.60 $26.20 $26.80 1 250
Feb 03, 2022 $26.62 $26.80 $26.40 $26.40 780
Feb 02, 2022 $26.98 $27.00 $26.40 $26.60 3 540
Feb 01, 2022 $27.40 $27.60 $26.40 $27.00 4 610
Jan 31, 2022 $28.00 $28.00 $26.60 $27.40 1 080
Jan 28, 2022 $28.00 $28.00 $25.80 $27.00 3 510
Jan 27, 2022 $27.60 $28.20 $26.10 $26.20 3 075
Jan 26, 2022 $26.76 $29.20 $26.76 $28.00 7 930
Jan 25, 2022 $27.60 $28.32 $26.20 $26.60 4 185
Jan 24, 2022 $27.80 $28.60 $25.80 $27.40 10 600
Jan 21, 2022 $29.40 $29.80 $28.40 $28.60 7 675
Jan 20, 2022 $29.16 $29.60 $28.40 $29.00 3 380
Jan 19, 2022 $29.60 $29.60 $28.40 $28.60 6 065
Click to get the best stock tips daily for free!

About Akari Therapeutics Plc

Akari Therapeutics Plc Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT